Insulin aspart biosimilar (Geropharm)
门冬胰岛素生物类似药（Geropharm）
Report date: 2025/01/21 20:00:10
Base Information
Drug NameInsulin aspart biosimilar (Geropharm)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGeropharm
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A